[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 1971

Bleomycin in Mycosis Fungoides and Reticulum Cell Lymphoma

Author Affiliations


From the Department of Dermatology (Drs. de Bast, Moriame, Wanet, Ledoux, and Achten), and the Department of Medicine and Clinical Investigation of the Institute J. Bordet, Tumors Center (Dr. Kenis), University of Brussels.

Arch Dermatol. 1971;104(5):508-512. doi:10.1001/archderm.1971.04000230050007

Bleomycin appears to be a useful drug to add to the therapeutic arsenal for the treatment of mycosis fungoides and reticulum cell lymphoma. Because of this drug's absence of hematological toxicity and the short duration of the remissions, we suggest its association with other cytostatics in the treatment of these two diseases.